Published in J Neurosurg on October 01, 2000
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed (2011) 1.39
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol (2008) 1.33
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer (2002) 1.26
Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol (2012) 1.16
Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol (2008) 1.05
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat. Acta Neuropathol (2011) 1.04
Classification and controversies in pathology of ependymomas. Childs Nerv Syst (2009) 1.02
Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro Oncol (2010) 1.01
Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. Neuro Oncol (2010) 0.99
Survival following treatment for intracranial ependymoma: a review. Childs Nerv Syst (2009) 0.95
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. PLoS One (2010) 0.94
Ependymoma. Childs Nerv Syst (2003) 0.92
Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas. J Clin Neurosci (2012) 0.90
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling. Neuro Oncol (2016) 0.81
Posterior fossa ependymomas: new radiological classification with surgical correlation. Childs Nerv Syst (2010) 0.80
Ependymomas in children. J Neurosurg (2000) 0.79
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes. Neuro Oncol (2010) 0.79
Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol (2008) 0.78
Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathol Commun (2016) 0.75
Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT). BMC Cancer (2006) 0.75
Quantitative imaging analysis of posterior fossa ependymoma location in children. Childs Nerv Syst (2016) 0.75
Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases. Pathol Oncol Res (2016) 0.75
Surgical considerations in fourth ventricular ependymoma with the transcerebellomedullary fissure approach in focus. Childs Nerv Syst (2009) 0.75
Recent Advances in the Classification and Treatment of Ependymomas. Curr Treat Options Oncol (2017) 0.75
Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) (2000) 3.95
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol (2001) 2.43
Use of rpoB gene analysis for detection and identification of Bartonella species. J Clin Microbiol (2001) 2.39
Elevated serum gastrin levels in patients with colorectal neoplasia. J Clin Gastroenterol (1991) 2.12
Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol (1982) 2.10
Identification of Bartonella (Rochalimaea) species among fastidious gram-negative bacteria on the basis of the partial sequence of the citrate-synthase gene. J Clin Microbiol (1995) 1.78
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70
Shunt implantation: reducing the incidence of shunt infection. J Neurosurg (1992) 1.69
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain (2001) 1.67
Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol (1993) 1.57
In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects. Arthritis Rheum (2006) 1.55
Brain abscess due to Gordona terrae in an immunocompromised child: case report and review of infections caused by G. terrae. Clin Infect Dis (1994) 1.53
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol (1991) 1.49
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol (2001) 1.48
31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology (1992) 1.47
Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. J Clin Oncol (1994) 1.40
Bent spine syndrome. J Neurol Neurosurg Psychiatry (1996) 1.38
[Value of endocervical margin examination of conization specimens. Prospective study conducted on 150 patients]. Gynecol Obstet Fertil (2000) 1.37
Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29
Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. Cancer Genet Cytogenet (1998) 1.27
Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis (2000) 1.27
Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant (2000) 1.27
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br J Cancer (1986) 1.25
Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet (1996) 1.25
Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study. J Neurol Sci (1984) 1.24
Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol (1992) 1.22
[Chronic spinal amyotrophy with paralysis of the vocal cords: Young-Harper syndrome]. Rev Neurol (Paris) (1984) 1.22
Infantile neuroaxonal dystrophy or Seitelberger's disease. II. Peripheral nerve involvement: electron microscopic study in one case. Acta Neuropathol (1971) 1.19
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer (2001) 1.18
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology (2003) 1.18
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer (1993) 1.17
[Infantile neuroaxonal dystrophy or Seitelberger's disease. 3. Ultrastructural study of striated muscle]. Acta Neuropathol (1971) 1.14
Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet (1998) 1.13
[Ultrastructural study of a tumor of the caudate nucleus in a case of Bourneville's disease]. Arch Anat Pathol (Paris) (1972) 1.13
Pituicytomas, a mis-diagnosed benign tumor of the neurohypophysis: report of three cases. Acta Neuropathol (2002) 1.11
The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology (1994) 1.10
Further histochemical studies on masticatory muscles. J Neurol Sci (1980) 1.09
Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol (1989) 1.08
Medical decision support systems: old dilemmas and new paradigms? Methods Inf Med (2003) 1.08
[Vertebrobasilar arterial dolichoectasia. Complications and prognosis]. Rev Neurol (Paris) (1991) 1.07
Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol (1998) 1.06
"Coated aorta": a new sign of Erdheim-Chester disease. J Rheumatol (2000) 1.06
Suprasellar hemangioblastoma. Surg Neurol (1984) 1.05
Esthesioneuroepithelioma, a true neurosensorial tumor. Light- and electron-microscopic study of a case with endocranial extension. Acta Neuropathol (1981) 1.05
Intracranial supratentorial cysts in children excluding tumor and parasitic cysts. Childs Brain (1978) 1.05
Multiple lateral meningoceles, distinctive facies and skeletal anomalies: a new case of Lehman syndrome. Clin Dysmorphol (1995) 1.04
Molecular identification of Staphylococcus lugdunensis in a patient with meningitis. J Clin Microbiol (2002) 1.04
[Aneurysms of the vein of Galen. Angiographic study and morphogenetic considerations]. Neurochirurgie (1987) 1.04
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring. Cancer Chemother Pharmacol (2007) 1.03
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer (2000) 1.03
Giant axonal neuropathy. Involvement of peripheral nerve, myenteric plexus and extra-neuronal area. Acta Neuropathol (1977) 1.02
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer (1997) 1.02
Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barré syndrome. J Neurol Sci (2000) 1.02
Ultrastructural studies of extraocular muscles in ocular motility disorders. II. Morphological analysis of 38 biopsies. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 1.02
Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer (1990) 1.02
CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle. Acta Neuropathol (1993) 1.02
Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol (1995) 1.00
CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies. Acta Neuropathol (2001) 1.00
Mortality and morbidity among elderly people with burns--evaluation of data on admission. Burns (2008) 1.00
Epilepsy and focal gyral anomalies detected by MRI: electroclinico-morphological correlations and follow-up. Dev Med Child Neurol (1992) 0.99
Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (2000) 0.98
Malignant transformation of an osteoblastoma of the skull: an exceptional occurrence. Case report. J Neurosurg (1991) 0.97
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer (2006) 0.97
Physeal and epiphyseal extent of primary malignant bone tumors in childhood. Correlation of preoperative MRI and the pathologic examination. Pediatr Radiol (1993) 0.97
Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci (1994) 0.97
Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children. Int J Pediatr Otorhinolaryngol (2010) 0.97
Intracranial meningiomas in children: review of 29 cases. Surg Neurol (1998) 0.97
Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique. Eur J Cancer (2002) 0.96
Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie Pédiatrique. Blood (1993) 0.96
Management of brain stem abscess. Br J Neurosurg (2001) 0.96
The relation between seborrheic keratoses and malignant solid tumours. A case-control study. Acta Derm Venereol (1991) 0.96
Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem (2001) 0.96
[Striatonigral degeneration associated with olivopontocerebellar atrophy. Anatomo-clinical study of 3 cases. Nosologic discussion]. Rev Neurol (Paris) (1983) 0.95
Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer's disease. Neurobiol Aging (2001) 0.95
Infantile neuroaxonal dystrophy or Seitelberger's disease. IV. Autonomic nervous system involvement: electron microscopic study in two siblings. Acta Neuropathol (1974) 0.95
Prognostic factors in pediatric spinal cord astrocytoma. Cancer (1998) 0.95
Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol (1999) 0.95
Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors. Acta Neuropathol (1995) 0.95
CD24, a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol (1996) 0.95
Extradural hematomas in children. 104 cases. Childs Brain (1975) 0.95
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. Eur J Cancer (2006) 0.94
[Clinical, light and electron microscopy findings in 4 cases of metachromatic leucodystrophy in children]. Acta Neuropathol (1972) 0.94
Physicians' acceptability of termination of pregnancy after prenatal diagnosis in southern France. Prenat Diagn (1989) 0.94
Giant central neurocytoma with tetraventricular and extra-axial extension. Case report. Acta Neurochir (Wien) (1995) 0.94